The global T-Cell Immunotherapy market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
By Types:
CAR-T
TCR
TIL Therapies
By Applications:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global T-Cell Immunotherapy Market Size Analysis from 2023 to 2028
1.5.1 Global T-Cell Immunotherapy Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global T-Cell Immunotherapy Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global T-Cell Immunotherapy Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: T-Cell Immunotherapy Industry Impact
Chapter 2 Global T-Cell Immunotherapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global T-Cell Immunotherapy (Volume and Value) by Type
2.1.1 Global T-Cell Immunotherapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global T-Cell Immunotherapy Revenue and Market Share by Type (2017-2022)
2.2 Global T-Cell Immunotherapy (Volume and Value) by Application
2.2.1 Global T-Cell Immunotherapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global T-Cell Immunotherapy Revenue and Market Share by Application (2017-2022)
2.3 Global T-Cell Immunotherapy (Volume and Value) by Regions
2.3.1 Global T-Cell Immunotherapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global T-Cell Immunotherapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global T-Cell Immunotherapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global T-Cell Immunotherapy Consumption by Regions (2017-2022)
4.2 North America T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America T-Cell Immunotherapy Market Analysis
5.1 North America T-Cell Immunotherapy Consumption and Value Analysis
5.1.1 North America T-Cell Immunotherapy Market Under COVID-19
5.2 North America T-Cell Immunotherapy Consumption Volume by Types
5.3 North America T-Cell Immunotherapy Consumption Structure by Application
5.4 North America T-Cell Immunotherapy Consumption by Top Countries
5.4.1 United States T-Cell Immunotherapy Consumption Volume from 2017 to 2022
5.4.2 Canada T-Cell Immunotherapy Consumption Volume from 2017 to 2022
5.4.3 Mexico T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 6 East Asia T-Cell Immunotherapy Market Analysis
6.1 East Asia T-Cell Immunotherapy Consumption and Value Analysis
6.1.1 East Asia T-Cell Immunotherapy Market Under COVID-19
6.2 East Asia T-Cell Immunotherapy Consumption Volume by Types
6.3 East Asia T-Cell Immunotherapy Consumption Structure by Application
6.4 East Asia T-Cell Immunotherapy Consumption by Top Countries
6.4.1 China T-Cell Immunotherapy Consumption Volume from 2017 to 2022
6.4.2 Japan T-Cell Immunotherapy Consumption Volume from 2017 to 2022
6.4.3 South Korea T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 7 Europe T-Cell Immunotherapy Market Analysis
7.1 Europe T-Cell Immunotherapy Consumption and Value Analysis
7.1.1 Europe T-Cell Immunotherapy Market Under COVID-19
7.2 Europe T-Cell Immunotherapy Consumption Volume by Types
7.3 Europe T-Cell Immunotherapy Consumption Structure by Application
7.4 Europe T-Cell Immunotherapy Consumption by Top Countries
7.4.1 Germany T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.2 UK T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.3 France T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.4 Italy T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.5 Russia T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.6 Spain T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.7 Netherlands T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.8 Switzerland T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.9 Poland T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 8 South Asia T-Cell Immunotherapy Market Analysis
8.1 South Asia T-Cell Immunotherapy Consumption and Value Analysis
8.1.1 South Asia T-Cell Immunotherapy Market Under COVID-19
8.2 South Asia T-Cell Immunotherapy Consumption Volume by Types
8.3 South Asia T-Cell Immunotherapy Consumption Structure by Application
8.4 South Asia T-Cell Immunotherapy Consumption by Top Countries
8.4.1 India T-Cell Immunotherapy Consumption Volume from 2017 to 2022
8.4.2 Pakistan T-Cell Immunotherapy Consumption Volume from 2017 to 2022
8.4.3 Bangladesh T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia T-Cell Immunotherapy Market Analysis
9.1 Southeast Asia T-Cell Immunotherapy Consumption and Value Analysis
9.1.1 Southeast Asia T-Cell Immunotherapy Market Under COVID-19
9.2 Southeast Asia T-Cell Immunotherapy Consumption Volume by Types
9.3 Southeast Asia T-Cell Immunotherapy Consumption Structure by Application
9.4 Southeast Asia T-Cell Immunotherapy Consumption by Top Countries
9.4.1 Indonesia T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.2 Thailand T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.3 Singapore T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.4 Malaysia T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.5 Philippines T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.6 Vietnam T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.7 Myanmar T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 10 Middle East T-Cell Immunotherapy Market Analysis
10.1 Middle East T-Cell Immunotherapy Consumption and Value Analysis
10.1.1 Middle East T-Cell Immunotherapy Market Under COVID-19
10.2 Middle East T-Cell Immunotherapy Consumption Volume by Types
10.3 Middle East T-Cell Immunotherapy Consumption Structure by Application
10.4 Middle East T-Cell Immunotherapy Consumption by Top Countries
10.4.1 Turkey T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.3 Iran T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.5 Israel T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.6 Iraq T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.7 Qatar T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.8 Kuwait T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.9 Oman T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 11 Africa T-Cell Immunotherapy Market Analysis
11.1 Africa T-Cell Immunotherapy Consumption and Value Analysis
11.1.1 Africa T-Cell Immunotherapy Market Under COVID-19
11.2 Africa T-Cell Immunotherapy Consumption Volume by Types
11.3 Africa T-Cell Immunotherapy Consumption Structure by Application
11.4 Africa T-Cell Immunotherapy Consumption by Top Countries
11.4.1 Nigeria T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.2 South Africa T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.3 Egypt T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.4 Algeria T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.5 Morocco T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 12 Oceania T-Cell Immunotherapy Market Analysis
12.1 Oceania T-Cell Immunotherapy Consumption and Value Analysis
12.2 Oceania T-Cell Immunotherapy Consumption Volume by Types
12.3 Oceania T-Cell Immunotherapy Consumption Structure by Application
12.4 Oceania T-Cell Immunotherapy Consumption by Top Countries
12.4.1 Australia T-Cell Immunotherapy Consumption Volume from 2017 to 2022
12.4.2 New Zealand T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 13 South America T-Cell Immunotherapy Market Analysis
13.1 South America T-Cell Immunotherapy Consumption and Value Analysis
13.1.1 South America T-Cell Immunotherapy Market Under COVID-19
13.2 South America T-Cell Immunotherapy Consumption Volume by Types
13.3 South America T-Cell Immunotherapy Consumption Structure by Application
13.4 South America T-Cell Immunotherapy Consumption Volume by Major Countries
13.4.1 Brazil T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.2 Argentina T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.3 Columbia T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.4 Chile T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.5 Venezuela T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.6 Peru T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.8 Ecuador T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in T-Cell Immunotherapy Business
14.1 Adaptimmune
14.1.1 Adaptimmune Company Profile
14.1.2 Adaptimmune T-Cell Immunotherapy Product Specification
14.1.3 Adaptimmune T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Altor Bioscience Corporation
14.2.1 Altor Bioscience Corporation Company Profile
14.2.2 Altor Bioscience Corporation T-Cell Immunotherapy Product Specification
14.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Cellectis
14.3.1 Cellectis Company Profile
14.3.2 Cellectis T-Cell Immunotherapy Product Specification
14.3.3 Cellectis T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Juno Therapeutics
14.4.1 Juno Therapeutics Company Profile
14.4.2 Juno Therapeutics T-Cell Immunotherapy Product Specification
14.4.3 Juno Therapeutics T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Kite Pharma
14.5.1 Kite Pharma Company Profile
14.5.2 Kite Pharma T-Cell Immunotherapy Product Specification
14.5.3 Kite Pharma T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Novartis
14.6.1 Novartis Company Profile
14.6.2 Novartis T-Cell Immunotherapy Product Specification
14.6.3 Novartis T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Takara Bio
14.7.1 Takara Bio Company Profile
14.7.2 Takara Bio T-Cell Immunotherapy Product Specification
14.7.3 Takara Bio T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Unum Therapeutics
14.8.1 Unum Therapeutics Company Profile
14.8.2 Unum Therapeutics T-Cell Immunotherapy Product Specification
14.8.3 Unum Therapeutics T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global T-Cell Immunotherapy Market Forecast (2023-2028)
15.1 Global T-Cell Immunotherapy Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global T-Cell Immunotherapy Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global T-Cell Immunotherapy Value and Growth Rate Forecast (2023-2028)
15.2 Global T-Cell Immunotherapy Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global T-Cell Immunotherapy Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global T-Cell Immunotherapy Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global T-Cell Immunotherapy Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global T-Cell Immunotherapy Consumption Forecast by Type (2023-2028)
15.3.2 Global T-Cell Immunotherapy Revenue Forecast by Type (2023-2028)
15.3.3 Global T-Cell Immunotherapy Price Forecast by Type (2023-2028)
15.4 Global T-Cell Immunotherapy Consumption Volume Forecast by Application (2023-2028)
15.5 T-Cell Immunotherapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 2450 |
Date : Apr 2024 |
| Category : Electronics |
Pages : 269 |
Request Sample 
Request Discount 
Inquire Before Buy
